25 XP   0   0   10

Cyduct Diagnostics Inc
Buy, Hold or Sell?

Let's analyse Cyduct Diagnostics Inc together

PenkeI guess you are interested in Cyduct Diagnostics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cyduct Diagnostics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cyduct Diagnostics Inc

I send you an email if I find something interesting about Cyduct Diagnostics Inc.

Quick analysis of Cyduct Diagnostics Inc (30 sec.)










What can you expect buying and holding a share of Cyduct Diagnostics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.44
Expected worth in 1 year
$-0.52
How sure are you?
0.0%

+ What do you gain per year?

Total Gains per Share
$-0.08
Return On Investment
-25.0%

For what price can you sell your share?

Current Price per Share
$0.31
Expected price per share
$0.3 - $0.35
How sure are you?
50%

1. Valuation of Cyduct Diagnostics Inc (5 min.)




Live pricePrice per Share (EOD)

$0.31

Intrinsic Value Per Share

$-0.74 - $-0.87

Total Value Per Share

$-1.18 - $-1.31

2. Growth of Cyduct Diagnostics Inc (5 min.)




Is Cyduct Diagnostics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.3m-$1.7m-$434.7k-20.1%

How much money is Cyduct Diagnostics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$111k-$123.5k$12.4k11.2%
Net Profit Margin-555.4%-527.6%--

How much money comes from the company's main activities?

3. Financial Health of Cyduct Diagnostics Inc (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

What can you expect buying and holding a share of Cyduct Diagnostics Inc? (5 min.)

Welcome investor! Cyduct Diagnostics Inc's management wants to use your money to grow the business. In return you get a share of Cyduct Diagnostics Inc.

What can you expect buying and holding a share of Cyduct Diagnostics Inc?

First you should know what it really means to hold a share of Cyduct Diagnostics Inc. And how you can make/lose money.

Speculation

The Price per Share of Cyduct Diagnostics Inc is $0.305. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cyduct Diagnostics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cyduct Diagnostics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.44. Based on the TTM, the Book Value Change Per Share is $-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cyduct Diagnostics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.02-7.4%-0.02-6.9%-0.02-7.7%-0.02-6.9%-0.02-6.9%
Usd Book Value Change Per Share-0.02-7.6%-0.02-6.3%-0.02-7.8%-0.03-11.1%-0.03-11.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-7.6%-0.02-6.3%-0.02-7.8%-0.03-11.1%-0.03-11.1%
Usd Price Per Share0.30-0.44-0.43-0.51-0.51-
Price to Earnings Ratio-3.31--5.30--4.54--6.60--6.60-
Price-to-Total Gains Ratio-13.03--26.58--18.09--27.60--27.60-
Price to Book Ratio-0.68--1.08--1.27--1.74--1.74-
Price-to-Total Gains Ratio-13.03--26.58--18.09--27.60--27.60-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.305
Number of shares3278
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.02-0.03
Usd Total Gains Per Share-0.02-0.03
Gains per Quarter (3278 shares)-62.52-110.93
Gains per Year (3278 shares)-250.08-443.72
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-250-2600-444-454
20-500-5100-887-898
30-750-7600-1331-1342
40-1000-10100-1775-1786
50-1250-12600-2219-2230
60-1500-15100-2662-2674
70-1751-17600-3106-3118
80-2001-20100-3550-3562
90-2251-22600-3993-4006
100-2501-25100-4437-4450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.013.00.00.0%0.013.00.00.0%0.013.00.00.0%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%0.013.00.00.0%0.013.00.00.0%0.013.00.00.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.013.00.0%0.00.013.00.0%0.00.013.00.0%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%0.013.00.00.0%0.013.00.00.0%0.013.00.00.0%

Fundamentals of Cyduct Diagnostics Inc

About Cyduct Diagnostics Inc

CYduct Diagnostics, Inc., a healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions. The company's products include breast endoscopy systems; 3-chip and 1-chip camera systems; cameras and accessories; endoscopic instruments, such as dissectors, graspers, scissors, needle holders, fan retractors, cautery instruments, and insufflation needles; and illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps. It also offers insufflators; laparoscopic instruments, such as general surgery, lymphadenectomy, gynecology, and thorascopy instruments; rigid scopes and accessories, including laparoscopes, operative scopes, cystoscopes, and scope trays; trocar and cannula sets, cannulas, trocars, reducer sleeves, and seals; video carts; instrument handles that include insulated handles and non-insulated handles; and veterinary instrumentation. The company was formerly known as Solos Endoscopy, Inc. and changed its name to CYduct Diagnostics, Inc. in December 2020. CYduct Diagnostics, Inc. was founded in 1986 and is based in Westport, Connecticut.

Fundamental data was last updated by Penke on 2024-05-16 00:03:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Cyduct Diagnostics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cyduct Diagnostics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cyduct Diagnostics Inc to the Medical Devices industry mean.
  • A Net Profit Margin of -570.8% means that $-5.71 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cyduct Diagnostics Inc:

  • The MRQ is -570.8%. The company is making a huge loss. -2
  • The TTM is -555.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-570.8%TTM-555.4%-15.4%
TTM-555.4%YOY-527.6%-27.8%
TTM-555.4%5Y-470.8%-84.6%
5Y-470.8%10Y-470.8%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-570.8%-10.8%-560.0%
TTM-555.4%-17.8%-537.6%
YOY-527.6%-13.1%-514.5%
5Y-470.8%-20.1%-450.7%
10Y-470.8%-25.0%-445.8%
1.1.2. Return on Assets

Shows how efficient Cyduct Diagnostics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cyduct Diagnostics Inc to the Medical Devices industry mean.
  • -262.2% Return on Assets means that Cyduct Diagnostics Inc generated $-2.62 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cyduct Diagnostics Inc:

  • The MRQ is -262.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -240.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-262.2%TTM-240.2%-22.0%
TTM-240.2%YOY-69.7%-170.5%
TTM-240.2%5Y-136.7%-103.5%
5Y-136.7%10Y-136.7%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-262.2%-3.6%-258.6%
TTM-240.2%-4.2%-236.0%
YOY-69.7%-3.9%-65.8%
5Y-136.7%-3.8%-132.9%
10Y-136.7%-4.3%-132.4%
1.1.3. Return on Equity

Shows how efficient Cyduct Diagnostics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cyduct Diagnostics Inc to the Medical Devices industry mean.
  • 0.0% Return on Equity means Cyduct Diagnostics Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cyduct Diagnostics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.6%+3.6%
TTM--4.7%+4.7%
YOY--4.6%+4.6%
5Y--5.6%+5.6%
10Y--5.7%+5.7%

1.2. Operating Efficiency of Cyduct Diagnostics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cyduct Diagnostics Inc is operating .

  • Measures how much profit Cyduct Diagnostics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cyduct Diagnostics Inc to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cyduct Diagnostics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--26.3%+26.3%
TTM--13.8%+13.8%
YOY--13.8%+13.8%
5Y--18.9%+18.9%
10Y--24.4%+24.4%
1.2.2. Operating Ratio

Measures how efficient Cyduct Diagnostics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 6.24 means that the operating costs are $6.24 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cyduct Diagnostics Inc:

  • The MRQ is 6.236. The company is inefficient in keeping operating costs low. -1
  • The TTM is 6.096. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.236TTM6.096+0.139
TTM6.096YOY5.936+0.160
TTM6.0965Y5.436+0.660
5Y5.43610Y5.4360.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2361.429+4.807
TTM6.0961.431+4.665
YOY5.9361.392+4.544
5Y5.4361.413+4.023
10Y5.4361.375+4.061

1.3. Liquidity of Cyduct Diagnostics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cyduct Diagnostics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.02 means the company has $0.02 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cyduct Diagnostics Inc:

  • The MRQ is 0.023. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.027. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.023TTM0.027-0.004
TTM0.027YOY0.143-0.116
TTM0.0275Y0.085-0.058
5Y0.08510Y0.0850.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0232.694-2.671
TTM0.0272.732-2.705
YOY0.1433.418-3.275
5Y0.0853.658-3.573
10Y0.0853.632-3.547
1.3.2. Quick Ratio

Measures if Cyduct Diagnostics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cyduct Diagnostics Inc to the Medical Devices industry mean.
  • A Quick Ratio of 0.02 means the company can pay off $0.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cyduct Diagnostics Inc:

  • The MRQ is 0.016. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.020. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.016TTM0.020-0.004
TTM0.020YOY0.132-0.112
TTM0.0205Y0.074-0.054
5Y0.07410Y0.0740.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0161.503-1.487
TTM0.0201.557-1.537
YOY0.1322.102-1.970
5Y0.0742.336-2.262
10Y0.0742.596-2.522

1.4. Solvency of Cyduct Diagnostics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cyduct Diagnostics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cyduct Diagnostics Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 51.90 means that Cyduct Diagnostics Inc assets are financed with 5,189.9% credit (debt) and the remaining percentage (100% - 5,189.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cyduct Diagnostics Inc:

  • The MRQ is 51.899. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 48.668. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ51.899TTM48.668+3.230
TTM48.668YOY11.010+37.658
TTM48.6685Y23.689+24.980
5Y23.68910Y23.6890.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ51.8990.414+51.485
TTM48.6680.399+48.269
YOY11.0100.335+10.675
5Y23.6890.441+23.248
10Y23.6890.454+23.235
1.4.2. Debt to Equity Ratio

Measures if Cyduct Diagnostics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cyduct Diagnostics Inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cyduct Diagnostics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.596-0.596
TTM-0.601-0.601
YOY-0.487-0.487
5Y-0.637-0.637
10Y-0.682-0.682

2. Market Valuation of Cyduct Diagnostics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cyduct Diagnostics Inc generates.

  • Above 15 is considered overpriced but always compare Cyduct Diagnostics Inc to the Medical Devices industry mean.
  • A PE ratio of -3.31 means the investor is paying $-3.31 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cyduct Diagnostics Inc:

  • The EOD is -3.364. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.309. Based on the earnings, the company is expensive. -2
  • The TTM is -5.295. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.364MRQ-3.309-0.055
MRQ-3.309TTM-5.295+1.986
TTM-5.295YOY-4.541-0.754
TTM-5.2955Y-6.597+1.302
5Y-6.59710Y-6.5970.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-3.364-1.091-2.273
MRQ-3.309-1.633-1.676
TTM-5.295-2.226-3.069
YOY-4.541-2.685-1.856
5Y-6.597-2.410-4.187
10Y-6.597-2.042-4.555
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cyduct Diagnostics Inc:

  • The EOD is -8.691. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.548. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -11.406. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.691MRQ-8.548-0.142
MRQ-8.548TTM-11.406+2.858
TTM-11.406YOY-8.542-2.864
TTM-11.4065Y12.009-23.415
5Y12.00910Y12.0090.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-8.691-1.979-6.712
MRQ-8.548-3.111-5.437
TTM-11.406-2.997-8.409
YOY-8.542-5.779-2.763
5Y12.009-5.345+17.354
10Y12.009-5.716+17.725
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cyduct Diagnostics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -0.68 means the investor is paying $-0.68 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cyduct Diagnostics Inc:

  • The EOD is -0.693. Based on the equity, the company is expensive. -2
  • The MRQ is -0.682. Based on the equity, the company is expensive. -2
  • The TTM is -1.082. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.693MRQ-0.682-0.011
MRQ-0.682TTM-1.082+0.400
TTM-1.082YOY-1.271+0.190
TTM-1.0825Y-1.741+0.659
5Y-1.74110Y-1.7410.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.6932.128-2.821
MRQ-0.6822.373-3.055
TTM-1.0822.549-3.631
YOY-1.2712.943-4.214
5Y-1.7414.024-5.765
10Y-1.7414.538-6.279
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Cyduct Diagnostics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.023-0.019-17%-0.024+3%-0.034+47%-0.034+47%
Book Value Per Share---0.440-0.412-6%-0.329-25%-0.318-28%-0.318-28%
Current Ratio--0.0230.027-15%0.143-84%0.085-73%0.085-73%
Debt To Asset Ratio--51.89948.668+7%11.010+371%23.689+119%23.689+119%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%
Eps---0.023-0.021-6%-0.024+4%-0.021-7%-0.021-7%
Free Cash Flow Per Share---0.009-0.010+16%-0.013+43%-0.009+7%-0.009+7%
Free Cash Flow To Equity Per Share--0.001-0.003+488%-0.004+617%-0.002+422%-0.002+422%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.871--------
Intrinsic Value_10Y_min---0.737--------
Intrinsic Value_1Y_max---0.048--------
Intrinsic Value_1Y_min---0.047--------
Intrinsic Value_3Y_max---0.173--------
Intrinsic Value_3Y_min---0.165--------
Intrinsic Value_5Y_max---0.335--------
Intrinsic Value_5Y_min---0.309--------
Market Cap1598462.300+2%1572258.0002319211.572-32%2244660.338-30%2686343.893-41%2686343.893-41%
Net Profit Margin---5.708-5.554-3%-5.276-8%-4.708-18%-4.708-18%
Operating Margin----0%-0%-0%-0%
Operating Ratio--6.2366.096+2%5.936+5%5.436+15%5.436+15%
Pb Ratio-0.693-2%-0.682-1.082+59%-1.271+86%-1.741+155%-1.741+155%
Pe Ratio-3.364-2%-3.309-5.295+60%-4.541+37%-6.597+99%-6.597+99%
Price Per Share0.305+2%0.3000.443-32%0.428-30%0.513-41%0.513-41%
Price To Free Cash Flow Ratio-8.691-2%-8.548-11.406+33%-8.5420%12.009-171%12.009-171%
Price To Total Gains Ratio-13.245-2%-13.028-26.581+104%-18.086+39%-27.599+112%-27.599+112%
Quick Ratio--0.0160.020-21%0.132-88%0.074-79%0.074-79%
Return On Assets---2.622-2.402-8%-0.697-73%-1.367-48%-1.367-48%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share---0.023-0.019-17%-0.024+3%-0.034+47%-0.034+47%
Usd Book Value---2305606.000-2160792.750-6%-1726020.250-25%-1668217.538-28%-1668217.538-28%
Usd Book Value Change Per Share---0.023-0.019-17%-0.024+3%-0.034+47%-0.034+47%
Usd Book Value Per Share---0.440-0.412-6%-0.329-25%-0.318-28%-0.318-28%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.023-0.021-6%-0.024+4%-0.021-7%-0.021-7%
Usd Free Cash Flow---45981.000-53109.500+16%-65921.250+43%-49154.538+7%-49154.538+7%
Usd Free Cash Flow Per Share---0.009-0.010+16%-0.013+43%-0.009+7%-0.009+7%
Usd Free Cash Flow To Equity Per Share--0.001-0.003+488%-0.004+617%-0.002+422%-0.002+422%
Usd Market Cap1598462.300+2%1572258.0002319211.572-32%2244660.338-30%2686343.893-41%2686343.893-41%
Usd Price Per Share0.305+2%0.3000.443-32%0.428-30%0.513-41%0.513-41%
Usd Profit---118780.000-111081.750-6%-123531.500+4%-110782.000-7%-110782.000-7%
Usd Revenue--20808.00022176.000-6%27343.750-24%26547.077-22%26547.077-22%
Usd Total Gains Per Share---0.023-0.019-17%-0.024+3%-0.034+47%-0.034+47%
 EOD+6 -2MRQTTM+7 -23YOY+15 -155Y+12 -1810Y+12 -18

3.2. Fundamental Score

Let's check the fundamental score of Cyduct Diagnostics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.364
Price to Book Ratio (EOD)Between0-1-0.693
Net Profit Margin (MRQ)Greater than0-5.708
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.016
Current Ratio (MRQ)Greater than10.023
Debt to Asset Ratio (MRQ)Less than151.899
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.622
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Cyduct Diagnostics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.717
Ma 20Greater thanMa 500.323
Ma 50Greater thanMa 1000.311
Ma 100Greater thanMa 2000.384
OpenGreater thanClose0.305
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-03-312023-06-302023-09-302023-12-312024-03-31
Other Stockholders Equity  -50-50-50-511,74311,738



Latest Balance Sheet

Balance Sheet of 2024-03-31. All numbers in thousands.

Summary
Total Assets45
Total Liabilities2,351
Total Stockholder Equity-2,306
 As reported
Total Liabilities 2,351
Total Stockholder Equity+ -2,306
Total Assets = 45

Assets

Total Assets45
Total Current Assets45
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 16
Net Receivables 16
Inventory 14
Total Current Assets  (as reported)45
Total Current Assets  (calculated)45
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,011
Long-term Liabilities340
Total Stockholder Equity-2,306
Total Current Liabilities
Short-term Debt 280
Accounts payable 115
Other Current Liabilities 1,616
Total Current Liabilities  (as reported)2,011
Total Current Liabilities  (calculated)2,011
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)340
Long-term Liabilities  (calculated)0
+/- 340
Total Stockholder Equity
Common Stock5
Retained Earnings -14,049
Other Stockholders Equity 11,738
Total Stockholder Equity (as reported)-2,306
Total Stockholder Equity (calculated)-2,306
+/-0
Other
Cash and Short Term Investments 16
Common Stock Shares Outstanding 5,241
Liabilities and Stockholders Equity 45
Net Debt 604
Net Working Capital -1,966
Short Long Term Debt Total 620



Balance Sheet

All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312012-03-312011-12-312011-09-302011-06-30
> Total Assets 
0
0
0
0
146
72
52
123
191
297
254
190
101
81
39
37
45
4537398110119025429719112352721460000
   > Total Current Assets 
458
422
395
411
96
72
52
123
191
297
254
190
101
81
39
37
45
45373981101190254297191123527296411395422458
       Cash And Cash Equivalents 
0
0
0
0
53
19
29
91
162
272
223
157
79
55
13
12
16
1612135579157223272162912919530000
       Net Receivables 
93
59
38
69
25
30
8
12
11
8
15
19
7
12
14
14
16
1614141271915811128302569385993
       Inventory 
260
257
251
229
18
24
15
20
18
17
15
14
15
14
12
11
14
14111214151415171820152418229251257260
   > Long-term Assets 
0
0
0
0
50
0
0
0
0
0
0
0
0
0
0
0
0
000000000000500000
       Property Plant Equipment 
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002
       Intangible Assets 
0
0
0
0
50
0
0
0
0
0
0
0
0
0
0
0
0
000000000000500000
> Total Liabilities 
0
0
0
0
1,249
1,197
1,257
1,423
1,598
1,847
1,927
1,965
2,007
2,104
2,168
2,222
2,351
2,3512,2222,1682,1042,0071,9651,9271,8471,5981,4231,2571,1971,2490000
   > Total Current Liabilities 
1,116
912
745
231
1,189
1,138
1,197
1,263
1,338
1,407
1,487
1,525
1,567
1,814
1,878
1,932
2,011
2,0111,9321,8781,8141,5671,5251,4871,4071,3381,2631,1971,1381,1892317459121,116
       Short-term Debt 
0
0
0
0
80
80
80
80
80
80
80
80
80
280
280
280
280
2802802802808080808080808080800000
       Accounts payable 
230
275
227
132
1,109
1,058
1,117
1,183
1,258
1,327
1,407
1,445
1,487
66
1,598
84
115
115841,598661,4871,4451,4071,3271,2581,1831,1171,0581,109132227275230
       Other Current Liabilities 
681
444
455
48
0
0
0
0
0
0
0
0
0
1,468
0
1,568
1,616
1,6161,56801,46800000000048455444681
   > Long-term Liabilities 
0
0
0
0
60
60
60
160
260
440
440
440
440
290
290
290
340
3402902902904404404404402601606060600000
> Total Stockholder Equity
0
0
0
0
-1,103
-1,125
-1,205
-1,300
-1,407
-1,551
-1,673
-1,774
-1,906
-2,023
-2,129
-2,185
-2,306
-2,306-2,185-2,129-2,023-1,906-1,774-1,673-1,551-1,407-1,300-1,205-1,125-1,1030000
   Common Stock
77
305
405
461
1,247
5
5
5
5
5
5
5
5
5
5
5
5
5555555555551,24746140530577
   Retained Earnings Total Equity00000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
11,630
11,694
11,694
11,694
11,694
11,694
11,694
11,694
11,694
11,694
11,694
11,743
0
011,74311,69411,69411,69411,69411,69411,69411,69411,69411,69411,69411,6300000
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
0
0
0
0
-1,247
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
-5
11,738
11,738-5-5-5-5-5-5-5-5-5-5-5-1,2470000



Balance Sheet

All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue119
Cost of Revenue-36
Gross Profit8383
 
Operating Income (+$)
Gross Profit83
Operating Expense-525
Operating Income-441-441
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense5250
 
Net Interest Income (+$)
Interest Income0
Interest Expense-31
Other Finance Cost-31
Net Interest Income0
 
Pretax Income (+$)
Operating Income-441
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-473-410
EBIT - interestExpense = -31
-473
-441
Interest Expense31
Earnings Before Interest and Taxes (EBIT)0-441
Earnings Before Interest and Taxes (EBITDA)-441
 
After tax Income (+$)
Income Before Tax-473
Tax Provision-0
Net Income From Continuing Ops0-473
Net Income-473
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses561
Total Other Income/Expenses Net-310
 

Technical Analysis of Cyduct Diagnostics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cyduct Diagnostics Inc. The general trend of Cyduct Diagnostics Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cyduct Diagnostics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cyduct Diagnostics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.35 < 0.35 < 0.35.

The bearish price targets are: 0.3 > 0.3 > 0.3.

Tweet this
Cyduct Diagnostics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cyduct Diagnostics Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cyduct Diagnostics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cyduct Diagnostics Inc. The current macd is 0.00433965.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cyduct Diagnostics Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Cyduct Diagnostics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Cyduct Diagnostics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Cyduct Diagnostics Inc Daily Moving Average Convergence/Divergence (MACD) ChartCyduct Diagnostics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cyduct Diagnostics Inc. The current adx is 66.69.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cyduct Diagnostics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Cyduct Diagnostics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cyduct Diagnostics Inc. The current sar is 0.35.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Cyduct Diagnostics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cyduct Diagnostics Inc. The current rsi is 34.72. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Cyduct Diagnostics Inc Daily Relative Strength Index (RSI) ChartCyduct Diagnostics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cyduct Diagnostics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cyduct Diagnostics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Cyduct Diagnostics Inc Daily Stochastic Oscillator ChartCyduct Diagnostics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cyduct Diagnostics Inc. The current cci is -49.38271605.

Cyduct Diagnostics Inc Daily Commodity Channel Index (CCI) ChartCyduct Diagnostics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cyduct Diagnostics Inc. The current cmo is -44.76962842.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Cyduct Diagnostics Inc Daily Chande Momentum Oscillator (CMO) ChartCyduct Diagnostics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cyduct Diagnostics Inc. The current willr is -90.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Cyduct Diagnostics Inc Daily Williams %R ChartCyduct Diagnostics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cyduct Diagnostics Inc.

Cyduct Diagnostics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cyduct Diagnostics Inc. The current atr is 0.00501693.

Cyduct Diagnostics Inc Daily Average True Range (ATR) ChartCyduct Diagnostics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cyduct Diagnostics Inc. The current obv is -4,400.

Cyduct Diagnostics Inc Daily On-Balance Volume (OBV) ChartCyduct Diagnostics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cyduct Diagnostics Inc. The current mfi is 77.68.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Cyduct Diagnostics Inc Daily Money Flow Index (MFI) ChartCyduct Diagnostics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cyduct Diagnostics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Cyduct Diagnostics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cyduct Diagnostics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.717
Ma 20Greater thanMa 500.323
Ma 50Greater thanMa 1000.311
Ma 100Greater thanMa 2000.384
OpenGreater thanClose0.305
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Cyduct Diagnostics Inc with someone you think should read this too:
  • Are you bullish or bearish on Cyduct Diagnostics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cyduct Diagnostics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cyduct Diagnostics Inc

I send you an email if I find something interesting about Cyduct Diagnostics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cyduct Diagnostics Inc.

Receive notifications about Cyduct Diagnostics Inc in your mailbox!